The global blood-based biomarker market is estimated to be valued at US$18,803.3 million in 2022 and is expected to exhibit a CAGR of 12.8% over the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.Market Overview:The blood-based biomarker market encompasses the use of various biomarkers found in blood samples for the diagnosis, prognosis, and...